Evidence map›Paper›PMID 21085187›Full record

SynthesisThe Journal of investigative dermatology2011

Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Stanca A Birlea, Ying Jin, Dorothy C Bennett, Deborah M Herbstman, Margaret R Wallace, Wayne T McCormack, E Helen Kemp, David J Gawkrodger, Anthony P Weetman, Mauro Picardo and 9 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in The Journal of investigative dermatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Exposome Risk Factors for Vitiligo: A Systematic Evidence Review.American journal of clinical dermatology · 2026
    Pooled it
  2. Pooled it
  3. Methodological strategies for mappingWorld journal of methodology · 2026
    Review
  4. Genetics of Vitiligo: A Review.Clinical, cosmetic and investigational dermatology · 2026
    Review
  5. Vitiligo.Nature reviews. Disease primers · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Aetiopathogenesis of Vitiligo.Dermatology practical & conceptual · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. The Role of the NKG2D in Vitiligo.Frontiers in immunology · 2021
    Review
  16. Review
  17. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.Clinical reviews in allergy & immunology · 2018
    Review
  18. Article
  19. Article
  20. Vitiligo and Autoimmune Thyroid Disorders.Frontiers in endocrinology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 5 countries.

Stanca A BirleaHuman Medical Genetics Program, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.
Ying Jin
Dorothy C Bennett
Deborah M Herbstman
Margaret R Wallace
Wayne T McCormack
E Helen Kemp
David J Gawkrodger
Anthony P Weetman
Mauro Picardo
Giovanni Leone
Alain Taïeb
Thomas Jouary
Khaled Ezzedine
Nanja van Geel
Jo Lambert
Andreas Overbeck
Pamela R Fain
Richard A Spritz
Hôpital Saint-André · FRUniversity of Colorado Denver · USUniversity of Florida · USGhent University Hospital · BEUniversity of Sheffield · GBRoyal Hallamshire Hospital · GBSan Gallicano Hospital · ITSt George's, University of London · GB

Funding

VitGene International Consortium to Identify Susceptibility Genes for GeneralizedR01AR056292 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SPRITZ, RICHARD ANDREW · 2008 to 2016
$6.9M
VitiligoR01AR045584 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SPRITZ, RICHARD ANDREW · 1999 to 2014
$6.2M
NIAMS NIH HHS R01 AR045584NIAMS NIH HHS R01 AR056292NIAMS NIH HHS R01 AR45584
6 · The paper itself

Abstract

We previously carried out a genome-wide association study of generalized vitiligo (GV) in non-Hispanic whites, identifying 13 confirmed susceptibility loci. In this study, we re-analyzed the genome-wide data set (comprising 1,392 cases and 2,629 controls) to specifically test association of all 33 GV candidate genes that have previously been suggested for GV, followed by meta-analysis incorporating both current and previously published data. We detected association of three of the candidate genes tested: TSLP (rs764916, P=3.0E-04, odds ratio (OR)=1.60; meta-P for rs3806933=3.1E-03), XBP1 (rs6005863, P=3.6E-04, OR=1.17; meta-P for rs2269577=9.5E-09), and FOXP3 (rs11798415, P=5.8E-04, OR=1.19). Association of GV with CTLA4 (rs12992492, P=5.9E-05, OR=1.20; meta-P for rs231775=1.0E-04) seems to be secondary to epidemiological association with other concomitant autoimmune diseases. Within the major histocompatibility complex (MHC), at 6p21.33, association with TAP1-PSMB8 (rs3819721, P=5.2E-06) seems to derive from linkage disequilibrium with major primary signals in the MHC class I and class II regions.

Indexed as

Case-Control StudiesCytokinesDNA-Binding ProteinsForkhead Transcription FactorsGenetic Predisposition to DiseaseHumansLinkage DisequilibriumPolymorphism, Single NucleotideRegulatory Factor X Transcription FactorsThymic Stromal LymphopoietinTranscription FactorsVitiligoX-Box Binding Protein 1CytokinesDNA-Binding ProteinsForkhead Transcription FactorsFOXP3 protein, humanRegulatory Factor X Transcription FactorsThymic Stromal LymphopoietinTranscription FactorsX-Box Binding Protein 1XBP1 protein, human

Identifiers

PMID21085187
PMCPMC3172683
OpenAlexW2047491064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.